20.35
price up icon4.41%   0.86
pre-market  시장 영업 전:  20.86   0.51   +2.51%
loading

Tonix Pharmaceuticals Holding Corp 주식(TNXP)의 최신 뉴스

pulisher
02:01 AM

How to build a dashboard for Tonix Pharmaceuticals Holding Corp. stockOil Prices & Capital Protection Trade Alerts - newser.com

02:01 AM
pulisher
12:37 PM

Is Tonix Pharmaceuticals Holding Corp. stock trading at a premium valuationMarket Sentiment Summary & Precise Swing Trade Alerts - newser.com

12:37 PM
pulisher
Oct 27, 2025

Sentiment analysis tools applied to Tonix Pharmaceuticals Holding Corp.M&A Rumor & Safe Entry Trade Reports - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Tonix Pharmaceuticals Holding Corp. stock trend forecastTrade Entry Report & Reliable Price Breakout Signals - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Tonix’s fibromyalgia drug shows significant pain reduction in study - Investing.com

Oct 27, 2025
pulisher
Oct 27, 2025

How to recover losses in Tonix Pharmaceuticals Holding Corp. stockTrade Exit Report & Low Drawdown Trading Strategies - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Tonix’s fibromyalgia drug shows significant pain reduction in study By Investing.com - Investing.com Nigeria

Oct 27, 2025
pulisher
Oct 27, 2025

Tonix Pharmaceuticals (TNXP) Unveils Positive Trial Results for Tonmya - GuruFocus

Oct 27, 2025
pulisher
Oct 27, 2025

Tonix Pharmaceuticals Presented Data on Tonmya™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2025 American College of Rheumatology (ACR) Convergence - The Manila Times

Oct 27, 2025
pulisher
Oct 27, 2025

Tonix PharmaceuticalsPrelim Q3 net revenue from product sales $3.3 millionSEC filing - MarketScreener

Oct 27, 2025
pulisher
Oct 27, 2025

Tonix (Nasdaq: TNXP) reports Phase 3 Tonmya fibromyalgia data: Week 14 pain reduction - Stock Titan

Oct 27, 2025
pulisher
Oct 27, 2025

Is Tonix Pharmaceuticals Holding Corp. stock a safe haven assetEarnings Overview Summary & Low Risk High Reward Ideas - newser.com

Oct 27, 2025
pulisher
Oct 24, 2025

First patient dosed in MGH-Led FOCUS study of Tonix’s investigational intranasal Oxytocin product - Proactive financial news

Oct 24, 2025
pulisher
Oct 24, 2025

Understanding Momentum Shifts in (TNXP) - news.stocktradersdaily.com

Oct 24, 2025
pulisher
Oct 23, 2025

Tonix: Assessing Tonmya's Commercial Potential Ahead Of Q4 2025 Launch - Seeking Alpha

Oct 23, 2025
pulisher
Oct 22, 2025

Tonix Pharmaceuticals (TNXP) Launches New Study for Rare Endocri - GuruFocus

Oct 22, 2025
pulisher
Oct 22, 2025

Can Tonix Pharmaceuticals Holding Corp. recover in the next quarterPortfolio Risk Report & Real-Time Volume Spike Alerts - newser.com

Oct 22, 2025
pulisher
Oct 22, 2025

Tonix (Nasdaq: TNXP) doses first patient in MGH FOCUS AVP-D study testing 6 IU and 24 IU - Stock Titan

Oct 22, 2025
pulisher
Oct 22, 2025

Tonix Pharmaceuticals Holding Corp. stock daily chart insightsTrade Risk Report & Daily Price Action Insights - newser.com

Oct 22, 2025
pulisher
Oct 21, 2025

Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2025 American College of Rheumatology (ACR) Convergence - The Manila Times

Oct 21, 2025
pulisher
Oct 21, 2025

Tonix Pharmaceuticals Announces Poster Presentation of Tonmya™ at 2025 American College of Rheumatology Convergence - Quiver Quantitative

Oct 21, 2025
pulisher
Oct 21, 2025

Tonix Pharma (Nasdaq: TNXP) to present Tonmya fibromyalgia data at ACR 2025 on Oct 27 - Stock Titan

Oct 21, 2025
pulisher
Oct 21, 2025

What analysts say about Tonix Pharmaceuticals Holding Corp stockSmall Cap Stock Opportunities & Small Investment Trading Growth - earlytimes.in

Oct 21, 2025
$37.26
price up icon 0.00%
$93.08
price up icon 1.97%
$29.03
price down icon 2.88%
$106.05
price up icon 0.37%
biotechnology ONC
$315.43
price up icon 1.49%
$164.02
price up icon 2.73%
자본화:     |  볼륨(24시간):